Search research articles
Contact Us
Filters
Showing results (11-20 of 21) with videos related to
Page
of 3
Sort By:
Psychopharmacology
|
November 27, 2004
Acute diclofenac treatment attenuates lipopolysaccharide-induced alterations to basic reward behavior and HPA axis activation in rats
Richard De La Garza, Gregory M Asnis, Kevin R Fabrizio, et al.
The Journal of Clinical Psychiatry
|
April 9, 2013
Efficacy and safety of levomilnacipran sustained release 40 mg, 80 mg, or 120 mg in major depressive disorder: a phase 3, randomized, double-blind, placebo-controlled study
Gregory M Asnis, Anjana Bose, Carl P Gommoll, et al.
Drug Safety
|
February 6, 2004
Safety and tolerability of lamotrigine for bipolar disorder
Charles L Bowden, Gregory M Asnis, Lawrence D Ginsberg, et al.
Journal of Clinical Psychopharmacology
|
May 15, 2009
Zolpidem extended-release improves sleep and next-day symptoms in comorbid insomnia and generalized anxiety disorder
Maurizio Fava, Gregory M Asnis, Ram Shrivastava, et al.
The International Tinnitus Journal
|
January 26, 2021
Insomnia in Tinnitus Patients: A Prospective Study Finding a Significant Relationship
Gregory M Asnis, Henderson Ma, Sylvester C, et al.
Behavioural Brain Research
|
January 24, 2004
The non-steroidal anti-inflammatory drug diclofenac sodium attenuates lipopolysaccharide-induced alterations to reward behavior and corticosterone release
Richard De La Garza, Kevin R Fabrizio, Gina Elena Radoi, et al.
Psychopharmacology Bulletin
|
November 11, 2003
IFN-induced depression: a role for NSAIDs
Gregory M Asnis, Richard De La Garza, Shari R Kohn, et al.
The Journal of Clinical Psychiatry
|
January 7, 2011
Improved insomnia symptoms and sleep-related next-day functioning in patients with comorbid major depressive disorder and insomnia following concomitant zolpidem extended-release 12.5 mg and escitalopram treatment: a randomized controlled trial
Maurizio Fava, Gregory M Asnis, Ram K Shrivastava, et al.
The Journal of Clinical Psychiatry
|
November 24, 2004
Effect of lamotrigine on cognitive complaints in patients with bipolar I disorder
Arifulla Khan, Lawrence D Ginsberg, Gregory M Asnis, et al.
Translational Psychiatry
|
July 25, 2024
Immune and neural response to acute social stress in adolescent humans and rodents
Vilma Gabbay, Benjamin A Ely, Julia N Vileisis, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 21) with videos related to
Sort By:
Page
of 3
Psychopharmacology
|
November 27, 2004
Acute diclofenac treatment attenuates lipopolysaccharide-induced alterations to basic reward behavior and HPA axis activation in rats
Richard De La Garza, Gregory M Asnis, Kevin R Fabrizio, et al.
The Journal of Clinical Psychiatry
|
April 9, 2013
Efficacy and safety of levomilnacipran sustained release 40 mg, 80 mg, or 120 mg in major depressive disorder: a phase 3, randomized, double-blind, placebo-controlled study
Gregory M Asnis, Anjana Bose, Carl P Gommoll, et al.
Drug Safety
|
February 6, 2004
Safety and tolerability of lamotrigine for bipolar disorder
Charles L Bowden, Gregory M Asnis, Lawrence D Ginsberg, et al.
Journal of Clinical Psychopharmacology
|
May 15, 2009
Zolpidem extended-release improves sleep and next-day symptoms in comorbid insomnia and generalized anxiety disorder
Maurizio Fava, Gregory M Asnis, Ram Shrivastava, et al.
The International Tinnitus Journal
|
January 26, 2021
Insomnia in Tinnitus Patients: A Prospective Study Finding a Significant Relationship
Gregory M Asnis, Henderson Ma, Sylvester C, et al.
Behavioural Brain Research
|
January 24, 2004
The non-steroidal anti-inflammatory drug diclofenac sodium attenuates lipopolysaccharide-induced alterations to reward behavior and corticosterone release
Richard De La Garza, Kevin R Fabrizio, Gina Elena Radoi, et al.
Psychopharmacology Bulletin
|
November 11, 2003
IFN-induced depression: a role for NSAIDs
Gregory M Asnis, Richard De La Garza, Shari R Kohn, et al.
The Journal of Clinical Psychiatry
|
January 7, 2011
Improved insomnia symptoms and sleep-related next-day functioning in patients with comorbid major depressive disorder and insomnia following concomitant zolpidem extended-release 12.5 mg and escitalopram treatment: a randomized controlled trial
Maurizio Fava, Gregory M Asnis, Ram K Shrivastava, et al.
The Journal of Clinical Psychiatry
|
November 24, 2004
Effect of lamotrigine on cognitive complaints in patients with bipolar I disorder
Arifulla Khan, Lawrence D Ginsberg, Gregory M Asnis, et al.
Translational Psychiatry
|
July 25, 2024
Immune and neural response to acute social stress in adolescent humans and rodents
Vilma Gabbay, Benjamin A Ely, Julia N Vileisis, et al.
Page
of 3